Arthur Knodel, MD
Critical Care Medicine · Tacoma, WANPI 1619960523
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.3% of the total across 80 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by GSK at 24.5% of the total. Reporting peaked in 2019 at $816 and has fallen 98.6% since, to $11 in 2022.
Across 80 payments — averaging $17.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$342
- Sunovion Pharmaceuticals Inc.$165
- Boehringer Ingelheim$115
- Actelion Pharmaceuticals US, Inc.$99
- Genentech USA, Inc.$93
- Astellas Pharma US Inc$72
- plus $509 from 16 others
What the payments were for
- Food & beverage$1,31694%
- Education$796%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 27 | $342 |
| Sunovion Pharmaceuticals Inc. | 9 | $165 |
| Boehringer Ingelheim | 5 | $115 |
| Actelion Pharmaceuticals US, Inc. | 4 | $99 |
| Genentech USA, Inc. | 4 | $93 |
| Astellas Pharma US Inc | 3 | $72 |
| Mylan Specialty L.p. | 3 | $58 |
| Sanofi | 3 | $52 |
| AstraZeneca | 2 | $46 |
| Philips North America LLC | 2 | $42 |
| United Therapeutics Corporation | 2 | $40 |
| AbbVie | 2 | $38 |
| Gilead | 2 | $37 |
| Insmed, Inc. | 2 | $35 |
| Merck | 2 | $35 |
| Novartis | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $20 |
| Pfizer | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Shire North American Group Inc | 1 | $12 |
| Amgen | 1 | $11 |
How this compares
$1,395 in reported general payments places this provider in the 85th percentile of 115 critical care medicine providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Tacoma
- Kurt JensenTacoma$6K
- Chelsea GarnerTacoma$5K
- Praful TewariTacoma$939
- Ramon AnelTacoma$594
- Joshua SnavelyTacoma$345
- Fahad AlroumiTacoma$223
- Britta KumleyTacoma$198
- Amanda SchillingTacoma$154
- Vinay GuptaSeattle$185K
- Sara NikravanSeattle$106K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.